A significant advance in cancer investigation is emerging with the use of mini-antibodies to re-engage mutated p53. This crucial tumor inhibitor protein is frequently lost in several types of cancer, leading https://listfav.com/story23815068/nanobodies-restore-the-p53-protein-a-new-hope-for-tumor-management